{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:21:50Z","timestamp":1791217310416,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microenvironment-mediated upregulation of the B-cell receptor (BCR) and nuclear factor-<jats:italic>\u03ba<\/jats:italic>B (NF-<jats:italic>\u03ba<\/jats:italic>B) signaling in CLL cells resident in the lymph node and bone marrow promotes apoptosis evasion and clonal expansion. We recently reported that MLN4924 (pevonedistat), an investigational agent that inhibits the NEDD8-activating enzyme (NAE), abrogates stromal-mediated NF-<jats:italic>\u03ba<\/jats:italic>B pathway activity and CLL cell survival. However, the NAE pathway also assists degradation of multiple other substrates. MLN4924 has been shown to induce DNA damage and cell cycle arrest, but the importance of this mechanism in primary neoplastic B cells has not been studied. Here we mimicked the lymph node microenvironment using CD40 ligand (CD40L)-expressing stroma and interleukin-21 (IL-21) to find that inducing proliferation of the primary CLL cells conferred enhanced sensitivity to NAE inhibition. Treatment of the CD40-stimulated CLL cells with MLN4924 resulted in deregulation of Cdt1, a DNA replication licensing factor, and cell cycle inhibitors p21 and p27. This led to DNA damage, checkpoint activation and G2 arrest. Alkylating agents bendamustine and chlorambucil enhanced MLN4924-mediated DNA damage and apoptosis. These events were more prominent in cells stimulated with IL-21 compared with CD40L alone, indicating that, following NAE inhibition, the culture conditions were able to direct CLL cell fate from an NF-<jats:italic>\u03ba<\/jats:italic>B inhibition to a Cdt1 induction program. Our data provide insight into the biological consequences of targeting NAE in CLL and serves as further rationale for studying the clinical activity of MLN4924 in CLL, particularly in combination with alkylating agents.<\/jats:p>","DOI":"10.1038\/cddis.2015.161","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T12:44:42Z","timestamp":1436445882000},"page":"e1807-e1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents"],"prefix":"10.1038","volume":"6","author":[{"given":"C","family":"Paiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Godbersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"BFcddis2015161_CR1","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/sj.onc.1207414","volume":"23","author":"ZQ Pan","year":"2004","unstructured":"Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K . Nedd8 on cullin: building an expressway to protein destruction. Oncogene 2004; 23: 1985\u20131997.","journal-title":"Oncogene"},{"key":"BFcddis2015161_CR2","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","volume":"114","author":"JA Burger","year":"2009","unstructured":"Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F . The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009; 114: 3367\u20133375.","journal-title":"Blood"},{"key":"BFcddis2015161_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011; 117: 563\u2013574.","journal-title":"Blood"},{"key":"BFcddis2015161_CR4","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/1078-0432.CCR-13-0987","volume":"20","author":"JC Godbersen","year":"2014","unstructured":"Godbersen JC, Humphries LA, Danilova OV, Kebbekus PE, Brown JR, Eastman A et al. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-kappaB activation and induces apoptosis in chronic lymphocytic leukemia B cells. Clin Cancer Res 2014; 20: 1576\u20131589.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015161_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm1547","volume":"6","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ . Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6: 9\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcddis2015161_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molcel.2009.12.024","volume":"37","author":"JE Brownell","year":"2010","unstructured":"Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, Bump NJ et al. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol Cell 2010; 37: 102\u2013111.","journal-title":"Mol Cell"},{"key":"BFcddis2015161_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009; 458: 732\u2013736.","journal-title":"Nature"},{"key":"BFcddis2015161_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","volume":"116","author":"MA Milhollen","year":"2010","unstructured":"Milhollen MA, Traore T, Adams-Duffy J, Thomas MP, Berger AJ, Dang L et al. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood 2010; 116: 1515\u20131523.","journal-title":"Blood"},{"key":"BFcddis2015161_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/0008-5472.CAN-11-2866","volume":"72","author":"D Wei","year":"2012","unstructured":"Wei D, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS et al. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res 2012; 72: 282\u2013293.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR10","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1038\/cddis.2012.125","volume":"3","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xiong X, Jia L, Sun Y . Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis. Cell Death Dis 2012; 3: e386.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015161_CR11","doi-asserted-by":"publisher","first-page":"e34079","DOI":"10.1371\/journal.pone.0034079","volume":"7","author":"D Yang","year":"2012","unstructured":"Yang D, Tan M, Wang G, Sun Y . The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. PLoS One 2012; 7: e34079.","journal-title":"PLoS One"},{"key":"BFcddis2015161_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrc1881","volume":"6","author":"KI Nakayama","year":"2006","unstructured":"Nakayama KI, Nakayama K . Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369\u2013381.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2015161_CR13","doi-asserted-by":"publisher","first-page":"e1013","DOI":"10.1038\/cddis.2013.552","volume":"5","author":"MA Dengler","year":"2014","unstructured":"Dengler MA, Weilbacher A, Gutekunst M, Staiger AM, Vohringer MC, Horn H et al. Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma. Cell Death Dis 2014; 5: e1013.","journal-title":"Cell Death Dis"},{"key":"BFcddis2015161_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/1947601910382899","volume":"1","author":"J Lee","year":"2010","unstructured":"Lee J, Zhou P . Cullins and cancer. Genes Cancer 2010; 1: 690\u2013699.","journal-title":"Genes Cancer"},{"key":"BFcddis2015161_CR15","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1158\/0008-5472.CAN-10-2062","volume":"70","author":"JJ Lin","year":"2010","unstructured":"Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A . NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res 2010; 70: 10310\u201310320.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR16","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1158\/0008-5472.CAN-10-2122","volume":"71","author":"MA Milhollen","year":"2011","unstructured":"Milhollen MA, Narayanan U, Soucy TA, Veiby PO, Smith PG, Amidon B . Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res 2011; 71: 3042\u20133051.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1158\/0008-5472.CAN-12-1729","volume":"73","author":"JL Blank","year":"2013","unstructured":"Blank JL, Liu XJ, Cosmopoulos K, Bouck DC, Garcia K, Bernard H et al. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. Cancer Res 2013; 73: 225\u2013234.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR18","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1182\/blood-2012-02-414060","volume":"120","author":"MS Davids","year":"2012","unstructured":"Davids MS, Deng J, Wiestner A, Lannutti BJ, Wang L, Wu CJ et al. Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia. Blood 2012; 120: 3501\u20133509.","journal-title":"Blood"},{"key":"BFcddis2015161_CR19","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1038\/onc.2010.248","volume":"29","author":"JM Tromp","year":"2010","unstructured":"Tromp JM, Tonino SH, Elias JA, Jaspers A, Luijks DM, Kater AP et al. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40\/TLR9 triggering. Oncogene 2010; 29: 5071\u20135082.","journal-title":"Oncogene"},{"key":"BFcddis2015161_CR20","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1182\/blood-2007-07-099531","volume":"111","author":"A Gowda","year":"2008","unstructured":"Gowda A, Roda J, Hussain SR, Ramanunni A, Joshi T, Schmidt S et al. IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood 2008; 111: 4723\u20134730.","journal-title":"Blood"},{"key":"BFcddis2015161_CR21","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1182\/blood-2012-11-467670","volume":"122","author":"MF Pascutti","year":"2013","unstructured":"Pascutti MF, Jak M, Tromp JM, Derks IA, Remmerswaal EB, Thijssen R et al. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. Blood 2013; 122: 3010\u20133019.","journal-title":"Blood"},{"key":"BFcddis2015161_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molcel.2006.09.010","volume":"24","author":"IF Davidson","year":"2006","unstructured":"Davidson IF, Li A, Blow JJ . Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision. Mol Cell 2006; 24: 433\u2013443.","journal-title":"Mol Cell"},{"key":"BFcddis2015161_CR23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/onc.2012.153","volume":"32","author":"C Mackintosh","year":"2013","unstructured":"Mackintosh C, Garcia-Dominguez DJ, Ordonez JL, Ginel-Picardo A, Smith PG, Sacristan MP et al. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells. Oncogene 2013; 32: 1441\u20131451.","journal-title":"Oncogene"},{"key":"BFcddis2015161_CR24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","volume":"282","author":"F Bunz","year":"1998","unstructured":"Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497\u20131501.","journal-title":"Science"},{"key":"BFcddis2015161_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/1078-0432.CCR-07-1061","volume":"14","author":"LM Leoni","year":"2008","unstructured":"Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, Corbeil J et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res 2008; 14: 309\u2013317.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015161_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/bjh.13042","volume":"167","author":"P Shindiapina","year":"2014","unstructured":"Shindiapina P, Brown JR, Danilov AV . A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53. Br J Haematol 2014; 167: 149\u2013161.","journal-title":"Br J Haematol"},{"key":"BFcddis2015161_CR27","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.1158\/1078-0432.CCR-08-0388","volume":"14","author":"G Roue","year":"2008","unstructured":"Roue G, Lopez-Guerra M, Milpied P, Perez-Galan P, Villamor N, Montserrat E et al. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling. Clin Cancer Res 2008; 14: 6907\u20136915.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015161_CR28","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1200\/JCO.2010.33.8061","volume":"29","author":"K Fischer","year":"2011","unstructured":"Fischer K, Cramer P, Busch R, Stilgenbauer S, Bahlo J, Schweighofer CD et al. Bendamustine combined with rituximab in patients with relapsed and\/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol 2011; 29: 3559\u20133566.","journal-title":"J Clin Oncol"},{"key":"BFcddis2015161_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1586\/14737140.2013.825424","volume":"13","author":"AV Danilov","year":"2013","unstructured":"Danilov AV, Soderquist RS, Bates DJ, Eastman A . Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts. Expert Rev Anticancer Ther 2013; 13: 1009\u20131012.","journal-title":"Expert Rev Anticancer Ther"},{"key":"BFcddis2015161_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","volume":"109","author":"T Endo","year":"2007","unstructured":"Endo T, Nishio M, Enzler T, Cottam HB, Fukuda T, James DF et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 2007; 109: 703\u2013710.","journal-title":"Blood"},{"key":"BFcddis2015161_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","volume":"244","author":"RC Rickert","year":"2011","unstructured":"Rickert RC, Jellusova J, Miletic AV . Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 2011; 244: 115\u2013133.","journal-title":"Immunol Rev"},{"key":"BFcddis2015161_CR32","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1182\/blood-2007-04-083832","volume":"110","author":"RN Damle","year":"2007","unstructured":"Damle RN, Temburni S, Calissano C, Yancopoulos S, Banapour T, Sison C et al. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 2007; 110: 3352\u20133359.","journal-title":"Blood"},{"key":"BFcddis2015161_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI23409","volume":"115","author":"BT Messmer","year":"2005","unstructured":"Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755\u2013764.","journal-title":"J Clin Invest"},{"key":"BFcddis2015161_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.molcel.2006.08.010","volume":"23","author":"J Jin","year":"2006","unstructured":"Jin J, Arias EE, Chen J, Harper JW, Walter JC . A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006; 23: 709\u2013721.","journal-title":"Mol Cell"},{"key":"BFcddis2015161_CR35","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1242\/jcs.100883","volume":"125","author":"K Klotz-Noack","year":"2012","unstructured":"Klotz-Noack K, McIntosh D, Schurch N, Pratt N, Blow JJ . Re-replication induced by geminin depletion occurs from G2 and is enhanced by checkpoint activation. J Cell Sci 2012; 125: 2436\u20132445.","journal-title":"J Cell Sci"},{"key":"BFcddis2015161_CR36","first-page":"2055","volume":"3","author":"MR Muller","year":"1997","unstructured":"Muller MR, Buschfort C, Thomale J, Lensing C, Rajewsky MF, Seeber S . DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia. Clin Cancer Res 1997; 3: 2055\u20132061.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2015161_CR37","first-page":"651","volume":"57","author":"C Buschfort","year":"1997","unstructured":"Buschfort C, Muller MR, Seeber S, Rajewsky MF, Thomale J . DNA excision repair profiles of normal and leukemic human lymphocytes: functional analysis at the single-cell level. Cancer Res 1997; 57: 651\u2013658.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/0008-5472.CAN-13-1536-T","volume":"74","author":"M Xie","year":"2014","unstructured":"Xie M, Yen Y, Owonikoko TK, Ramalingam SS, Khuri FR, Curran WJ et al. Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase. Cancer Res 2014; 74: 212\u2013223.","journal-title":"Cancer Res"},{"key":"BFcddis2015161_CR39","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1200\/JCO.2011.39.2688","volume":"30","author":"K Fischer","year":"2012","unstructured":"Fischer K, Cramer P, Busch R, Bottcher S, Bahlo J, Schubert J et al. Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol 2012; 30: 3209\u20133216.","journal-title":"J Clin Oncol"},{"key":"BFcddis2015161_CR40","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1200\/JCO.2008.18.7252","volume":"27","author":"BD Cheson","year":"2009","unstructured":"Cheson BD, Rummel MJ . Bendamustine: rebirth of an old drug. J Clin Oncol 2009; 27: 1492\u20131501.","journal-title":"J Clin Oncol"},{"key":"BFcddis2015161_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00001813-199606000-00007","volume":"7","author":"D Strumberg","year":"1996","unstructured":"Strumberg D, Harstrick A, Doll K, Hoffmann B, Seeber S . Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Anticancer Drugs 1996; 7: 415\u2013421.","journal-title":"Anticancer Drugs"},{"key":"BFcddis2015161_CR42","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1158\/1541-7786.MCR-11-0497","volume":"10","author":"Y Kee","year":"2012","unstructured":"Kee Y, Huang M, Chang S, Moreau LA, Park E, Smith PG et al. Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents. Mol Cancer Res 2012; 10: 369\u2013377.","journal-title":"Mol Cancer Res"},{"key":"BFcddis2015161_CR43","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/blood-2013-12-541433","volume":"123","author":"AA El-Mabhouh","year":"2014","unstructured":"El-Mabhouh AA, Ayres ML, Shpall EJ, Baladandayuthapani V, Keating MJ, Wierda WG et al. Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells. Blood 2014; 123: 3780\u20133789.","journal-title":"Blood"},{"key":"BFcddis2015161_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/intimm\/dxh377","volume":"18","author":"S Neron","year":"2006","unstructured":"Neron S, Suck G, Ma XZ, Sakac D, Roy A, Katsman Y et al. B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase. Int Immunol 2006; 18: 375\u2013387.","journal-title":"Int Immunol"},{"key":"BFcddis2015161_CR45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bjh.12580","volume":"163","author":"LA Humphries","year":"2013","unstructured":"Humphries LA, Godbersen JC, Danilova OV, Kaur P, Christensen BC, Danilov AV . Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia. Br J Haematol 2013; 163: 590\u2013602.","journal-title":"Br J Haematol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2015161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:07:47Z","timestamp":1672913267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2015161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"alternative-id":["BFcddis2015161"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2015.161","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]},"assertion":[{"value":"2 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Allison Berger is an employee of Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}